Cachet Pharmaceutical Co., Ltd.
Символ: 002462.SZ
SHZ
12.28
CNYПазарна цена днес
10.4775
Съотношение P/E
7.0898
Коефициент PEG
3.58B
MRK Cap
- 0.03%
Доходност на DIV
Cachet Pharmaceutical Co., Ltd. (002462-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 9703.21 | 2183.7 | 2338.4 | 2018.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.61 | 0.2 | 0.2 | -6.8 | ||||||||||||||||
balance-sheet.row.net-receivables | 41668.13 | 9948 | 8640.8 | 8440.3 | ||||||||||||||||
balance-sheet.row.inventory | 7944.71 | 2692.3 | 2185.4 | 2013.6 | ||||||||||||||||
balance-sheet.row.other-current-assets | 661.19 | 171.6 | 120.8 | 94.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 60531.37 | 14995.6 | 13285.3 | 12567.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 2890.04 | 735.9 | 850.3 | 795.5 | ||||||||||||||||
balance-sheet.row.goodwill | 2063.66 | 515.9 | 562.4 | 576.1 | ||||||||||||||||
balance-sheet.row.intangible-assets | 142.92 | 35.8 | 36.6 | 31 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2206.58 | 551.7 | 599 | 607.1 | ||||||||||||||||
balance-sheet.row.long-term-investments | 9.16 | 2.3 | 2.3 | 9.3 | ||||||||||||||||
balance-sheet.row.tax-assets | 314.48 | 68.1 | 52.6 | 56.4 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 795.3 | 203 | 148.2 | 98.3 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 6215.56 | 1561 | 1652.3 | 1566.6 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 66746.93 | 16556.6 | 14937.5 | 14133.7 | ||||||||||||||||
balance-sheet.row.account-payables | 22506.88 | 5319.5 | 4442.4 | 4094.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 15256.43 | 4068 | 3774.5 | 3602.7 | ||||||||||||||||
balance-sheet.row.tax-payables | 378.98 | 96.8 | 99.8 | 116.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 850.46 | 208.8 | 229.2 | 176.1 | ||||||||||||||||
Deferred Revenue Non Current | -12.17 | 0 | 0 | -37.3 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 47.12 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 1527.22 | 732.8 | 34 | 41.2 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 897.57 | 220 | 259.2 | 213.3 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 850.46 | 208.8 | 229.2 | 176.1 | ||||||||||||||||
balance-sheet.row.total-liab | 42640.52 | 10635 | 9281 | 8809.7 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 1166.83 | 291.7 | 291.7 | 291.7 | ||||||||||||||||
balance-sheet.row.retained-earnings | 9351.6 | 2268.1 | 2079.1 | 1858.4 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3516.49 | 240 | 237.6 | 200.6 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 2556.4 | 1278.2 | 1278.2 | 1278.2 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 16591.32 | 4078 | 3886.5 | 3628.9 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 66746.93 | 16556.6 | 14937.5 | 14133.7 | ||||||||||||||||
balance-sheet.row.minority-interest | 7515.09 | 1843.6 | 1770 | 1695.1 | ||||||||||||||||
balance-sheet.row.total-equity | 24106.41 | 5921.6 | 5656.6 | 5324 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 66746.93 | - | - | - | ||||||||||||||||
Total Investments | 9.77 | 2.4 | 2.5 | 2.5 | ||||||||||||||||
balance-sheet.row.total-debt | 16106.89 | 4276.8 | 4003.8 | 3778.8 | ||||||||||||||||
balance-sheet.row.net-debt | 6404.28 | 2093.2 | 1665.6 | 1760.3 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 335.77 | 468.3 | 601.9 | 590.9 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 110.03 | 226.7 | 201.1 | 175.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 34.3 | 3.5 | -0.3 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -2948.36 | -1216.3 | -133.8 | -47.7 | ||||||||||||||||
cash-flows.row.account-receivables | -2437.66 | -2437.7 | -655.1 | -699 | ||||||||||||||||
cash-flows.row.inventory | -510.71 | -510.7 | -179.8 | 183.5 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 1766.3 | 704.7 | 467.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | -34.3 | -3.5 | 0.3 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 2818.58 | 357.8 | 243.9 | 395.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 316.01 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -186.63 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.acquisitions-net | 92.8 | -1.6 | 59.2 | 1.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40.39 | 0 | -16.2 | -42 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -48.57 | 10.9 | 2.3 | 1 | ||||||||||||||||
cash-flows.row.other-investing-activites | 12.46 | 3.8 | -55.5 | 4.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -170.33 | -175.4 | -257.1 | -293.5 | ||||||||||||||||
cash-flows.row.debt-repayment | -5748.94 | -4619.6 | -3975.2 | -4948.4 | ||||||||||||||||
cash-flows.row.common-stock-issued | 37.5 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -37.5 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -372.58 | -282.3 | -242.7 | -289.1 | ||||||||||||||||
cash-flows.row.other-financing-activites | 5059.73 | 4739.1 | 3884.8 | 4864 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -1061.78 | -162.8 | -333.1 | -373.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1099.55 | 0 | -0.7 | -0.4 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 183.45 | -501.7 | 322.2 | 447.4 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 7888.8 | 1699.3 | 2201 | 1878.8 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 7705.35 | 2201 | 1878.8 | 1431.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 316.01 | -163.4 | 913.1 | 1114.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -186.63 | -188.5 | -247 | -258 | ||||||||||||||||
cash-flows.row.free-cash-flow | 129.38 | -352 | 666.2 | 856.9 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 27726.67 | 26219.8 | 25625.6 | 23256.1 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 25613.35 | 24112.2 | 23484.9 | 21122 | ||||||||||||||||
income-statement-row.row.gross-profit | 2113.32 | 2107.6 | 2140.8 | 2134.2 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 2.72 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 55.38 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 866.63 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 257.48 | 263.7 | 234.2 | 192.8 | ||||||||||||||||
income-statement-row.row.operating-expenses | 1196.14 | 1162 | 1103.7 | 933.4 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 26809.49 | 25274.3 | 24588.6 | 22055.4 | ||||||||||||||||
income-statement-row.row.interest-income | 149.78 | -22.4 | 17.1 | 20.2 | ||||||||||||||||
income-statement-row.row.interest-expense | 124.74 | 175.3 | 164.2 | 180.8 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 866.63 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1.57 | -292 | -6.8 | -380.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 257.48 | 263.7 | 234.2 | 192.8 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -1.57 | -292 | -6.8 | -380.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 124.74 | 175.3 | 164.2 | 180.8 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 366.08 | 226.7 | 408.3 | 175.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 956.06 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 589.98 | 936.9 | 830.8 | 1194.9 | ||||||||||||||||
income-statement-row.row.income-before-tax | 588.42 | 644.9 | 824 | 814.3 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 159.68 | 176.6 | 222.1 | 223.4 | ||||||||||||||||
income-statement-row.row.net-income | 335.77 | 468.3 | 601.9 | 590.9 |
Често задавани въпроси
Какво е Cachet Pharmaceutical Co., Ltd. (002462.SZ) общи активи?
Cachet Pharmaceutical Co., Ltd. (002462.SZ) общите активи са 16556608348.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 15031575006.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.444.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.444.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.012.
Какъв е общият приход на предприятието?
Общият приход е 0.021.
Каква е Cachet Pharmaceutical Co., Ltd. (002462.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 468312507.000.
Какъв е общият дълг на фирмата?
Общият дълг е 4276753801.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 1162028942.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 2212200857.000.